Sagimet Biosciences Inc. (SGMT) P/B ratio

P/B ratio today
2.9×

Sagimet Biosciences Inc. (SGMT) trades at 2.9× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 1.7×. That is 89.9% higher than the 0.9× of fiscal 2024. Figures as of 18 Nov 2026, 11:35 UTC, from Yahoo Finance.

Key facts

P/B ratio today
2.9×
P/B ratio, fiscal 2025
1.7×
Change on fiscal 2024
+89.9%
Highest on record
1.7×fiscal 2025
Lowest on record
0.6×fiscal 2023
Fiscal years on record
32023–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Sagimet Biosciences Inc. P/B ratio, in more detail

Today's figure is 66.4% above the fiscal 2025 year-end.

Across the 3 fiscal year-ends on record (2023–2025), the highest was 1.7× in fiscal 2025 and the lowest 0.6× in fiscal 2023. Today's P/B ratio is above every one of the 3 fiscal year-ends on record; their median is 0.9×.

History · 3 fiscal years

P/B ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Sagimet Biosciences Inc. P/B ratio, year by year

Sagimet Biosciences Inc. (SGMT) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
Today2.9×—$9.85—
20251.7× 89.9% up$5.92$3.44
20240.9× 45.4% up$4.50$4.97
20230.6×—$5.42$8.71
2022———-$8.43

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

More on SGMT

Sagimet Biosciences Inc., figure by figure

Sagimet Biosciences Inc. (SGMT) overview: price, valuation and scorecard

Sagimet Biosciences Inc. P/B ratio: questions and answers

What is Sagimet Biosciences Inc.'s P/B ratio?

Sagimet Biosciences Inc. (SGMT) trades at 2.9× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 1.7×. That is 89.9% higher than the 0.9× of fiscal 2024.

Is Sagimet Biosciences Inc.'s P/B ratio high or low compared with its own history?

Today's P/B ratio is above every one of the 3 fiscal year-ends on record; their median is 0.9×.

What are the highest and lowest P/B ratio figures on record for Sagimet Biosciences Inc.?

Across the 3 fiscal year-ends on record (2023–2025), the highest was 1.7× in fiscal 2025 and the lowest 0.6× in fiscal 2023.

How is Sagimet Biosciences Inc.'s P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For Sagimet Biosciences Inc. it is on record here for 3 fiscal years, 2023 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Sagimet Biosciences Inc. (SGMT) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/SGMT/pb-ratio

Underlying data: Yahoo Finance.